SI0918536T1 - Composition comprising insulin and insulin-like growth factor-i (igf-i) - Google Patents
Composition comprising insulin and insulin-like growth factor-i (igf-i)Info
- Publication number
- SI0918536T1 SI0918536T1 SI9730204T SI9730204T SI0918536T1 SI 0918536 T1 SI0918536 T1 SI 0918536T1 SI 9730204 T SI9730204 T SI 9730204T SI 9730204 T SI9730204 T SI 9730204T SI 0918536 T1 SI0918536 T1 SI 0918536T1
- Authority
- SI
- Slovenia
- Prior art keywords
- insulin
- igf
- composition
- growth factor
- growth
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 title 1
- 102100037852 Insulin-like growth factor I Human genes 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/696,314 US5783556A (en) | 1996-08-13 | 1996-08-13 | Formulated insulin-containing composition |
| PCT/US1997/013566 WO1998006423A1 (en) | 1996-08-13 | 1997-07-31 | Composition comprising insulin and insulin-like growth factor-i (igf-i) |
| EP97935259A EP0918536B1 (en) | 1996-08-13 | 1997-07-31 | Composition comprising insulin and insulin-like growth factor-i (igf-i) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI0918536T1 true SI0918536T1 (en) | 2002-10-31 |
Family
ID=26148761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9730204T SI0918536T1 (en) | 1996-08-13 | 1997-07-31 | Composition comprising insulin and insulin-like growth factor-i (igf-i) |
Country Status (1)
| Country | Link |
|---|---|
| SI (1) | SI0918536T1 (en) |
-
1997
- 1997-07-31 SI SI9730204T patent/SI0918536T1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL128128A0 (en) | Composition comprising insulin and insulin-like growth factor-i (igf-i) | |
| AU2601895A (en) | Modified insulin-like growth factors | |
| IL143834A0 (en) | Insulin-like growth factor (igf) i mutant variants | |
| PL314003A1 (en) | Combination of bisulphonates and substances enhancing secretion of growth hormone | |
| AU3220097A (en) | Sleep quality improvement using a growth hormone secretagogue | |
| EP0682654A4 (en) | Benzo-fused lactams promote release of growth hormone. | |
| HUP9902476A3 (en) | A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent | |
| GB2316228B (en) | High contrast electroluminescent displays | |
| AU1752697A (en) | Deicing composition and method | |
| AU1087295A (en) | Bone marrow transplantation | |
| AU2534397A (en) | Deicing composition and method | |
| IL136377A0 (en) | Glucagon-like peptide-1 crystals | |
| HUP9904156A3 (en) | Insulin preparations containing carbohydrates | |
| NZ218811A (en) | Insulin-like growth factor-i proteins and dna sequences | |
| AU3211297A (en) | Picture card | |
| ZA971412B (en) | Benzothiophenes formulations containing same and methods | |
| IL144350A0 (en) | Growth hormone secretagogues | |
| AUPM678294A0 (en) | Use of insulin-like growth factor in combination with insulin | |
| GB9412629D0 (en) | Improvements in crystal growth | |
| EP0546081A4 (en) | New insulin-like growth factor binding protein (igfbp-4) | |
| SI0918536T1 (en) | Composition comprising insulin and insulin-like growth factor-i (igf-i) | |
| ZA974785B (en) | Growth hormone and estrogen in the treatment of osteoporosis. | |
| GB9616700D0 (en) | Hormone supplement | |
| AU9293598A (en) | The use of insulin-like growth factor-i in muscle | |
| IL114063A0 (en) | Solution comprising IGF-I or any functional analogue thereof and method for its preparation |